Longboard Pharmaceuticals Inc (LBPH) Stock
LBPH is no longer traded. Longboard Pharmaceuticals was acquired by Lundbeck on December 2, 2024.
Each LBPH share was exchanged for $60.00 in cash. Prices on this page are historical; the last trade was November 29, 2024 at $59.98.
Longboard Pharmaceuticals stock price history
LBPH final trading statistics
- Final close
- $59.98
- Final trading day
- Nov 29, 2024
- Market cap at delisting
- $2.07B
- Shares outstanding
- 34.44M
- Final 52-week range
- $3.65 – $60.03
- Avg. volume (final 3 mo.)
- 1,736,911
- All-time high (split-adj.)
- $59.98 · Nov 2024
- All-time low (split-adj.)
- $2.95 · Jul 2022
- Return since IPO
- +260.2%
- Beta
- 1.09
- Book value / share
- $7.05
- Price / book
- 8.51
Longboard Pharmaceuticals annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $0.00 | -$54.4M | -$2.38 |
| FY2022 | $0.00 | -$43.1M | -$2.57 |
| FY2021 | $0.00 | -$27.7M | -$2.15 |
| FY2020 | $0.00 | -$14.4M | -$0.85 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Longboard Pharmaceuticals Inc
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel and transformative medicines for neurological diseases. The company develops bexicaserin (LP352), which has completed Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. It also develops LP659, an S1P receptor modulator for the treatment of neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California. As of December 2, 2024, Longboard Pharmaceuticals, Inc. operates as a subsidiary of Langkawi Corporation.
Longboard Pharmaceuticals stock FAQ
What happened to Longboard Pharmaceuticals stock?
Longboard Pharmaceuticals was acquired by Lundbeck on December 2, 2024. Shareholders received $60.00 in cash for each share. LBPH stock stopped trading on the Nasdaq, with a final close of $59.98 on November 29, 2024.
What did Longboard Pharmaceuticals shareholders receive?
Each LBPH share was converted into $60.00 in cash. The deal was valued at about $2.6 billion.
Is LBPH stock still trading?
No. LBPH was delisted from the Nasdaq on December 2, 2024 and no longer trades on a U.S. exchange.
What was the last price of LBPH stock?
LBPH closed at $59.98 on its final trading day, November 29, 2024, for a market value of about $2.07B.
What were Longboard Pharmaceuticals's revenue and earnings in its last full fiscal year?
Longboard Pharmaceuticals reported revenue of $0.00 and net income of -$54.4M in fiscal 2023, its last full year as a public company.
When did Longboard Pharmaceuticals go public?
Longboard Pharmaceuticals Inc stock began trading on March 12, 2021.